A Phase I Trial of CCT303-406 in Patients With Relapsed or Refractory HER2 Positive Solid Tumors
Conditions: Solid Tumor; Gastric Cancer; Breast Cancer; Ovarian Cancer; Sarcoma Intervention: Biological: CCT303-406 Sponsors: Shanghai PerHum Therapeutics Co., Ltd.; Shanghai Zhongshan Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials